CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Mar. 29, 2024	Mar. 31, 2023
Operating Activities
Net income	$ 10,313	$ 8,189
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation of property, plant and equipment	3,077	4,193
Amortization of intangible assets	651	372
Provision for uncollectible receivables	569	476
Share-based compensation	5,545	5,135
Deferred taxes	2,180	5,189
Inventory write-downs	3,589	1,715
Noncash lease expense	575	524
Net (gain) loss on marketable securities	(61)	1,730
Other non-cash operating activities, net	83	34
Changes in operating assets and liabilities:
Accounts receivable	14,312	(12,212)
Unbilled receivables	(17,039)	(17,719)
Inventories	7,037	(9,919)
Accounts payable	(8,841)	16,344
Accrued expenses	11,449	(3,594)
Advance payments and unearned revenue	(4,213)	1,948
Income taxes	1,099	1,932
Other assets and liabilities	(8,096)	(13,342)
Net cash provided by (used in) operating activities	22,229	(9,005)
Investing Activities
Purchase of property, plant and equipment	(1,866)	(5,055)
Purchase of marketable securities	(925)	0
Proceeds from sale of marketable securities	0	9,163
Acquisition, net of cash acquired	(32,162)	(15,769)
Net cash used in investing activities	(34,953)	(11,661)
Financing Activities
Proceeds from revolver	33,200	50,200
Repayments of revolver	(33,200)	(44,000)
Proceeds from term loan	50,000	0
Repayments of term loan	(625)	0
Payments of deferred financing costs	(79)	0
Payments for repurchase of common stock - treasury shares	(332)	0
Payments for taxes related to net settlement of equity awards	(690)	(1,055)
Proceeds from issuance of common stock under employee stock plans	1,005	1,074
Net cash provided by financing activities	49,279	6,219
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	(597)	9
Net increase (decrease) in cash, cash equivalents, and restricted cash	35,958	(14,438)
Cash, cash equivalents, and restricted cash, beginning of period	22,521	37,104
Cash, cash equivalents, and restricted cash, end of period	58,479	22,666
Non-cash investing and financing activities:
Common stock issued in connection with acquisition	$ 22,331	$ 0